341 related articles for article (PubMed ID: 6732259)
1. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
Stern RS; Momtaz K
Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
[TBL] [Abstract][Full Text] [Related]
2. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
Bech-Thomsen N; Angelo HR; Wulf HC
Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
[TBL] [Abstract][Full Text] [Related]
3. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB
N Engl J Med; 1979 Apr; 300(15):809-13. PubMed ID: 423919
[TBL] [Abstract][Full Text] [Related]
4. Photochemotherapy of psoriasis using methoxsalen and sunlight. A controlled study.
Parrish JA; White AD; Kingsbury T; Zahar M; Fitzpatrick TB
Arch Dermatol; 1977 Nov; 113(11):1529-32. PubMed ID: 337903
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis.
Boer J; Hermans J; Schothorst AA; Suurmond D
Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715
[TBL] [Abstract][Full Text] [Related]
6. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
Roelandts R
Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():11-21. PubMed ID: 22512676
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
Dayal S; ; Jain VK
Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
[TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
15. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
16. [Technical experience with 8-methoxypsoralen photochemotherapy in common psoriasis].
Hofmann C; Plewig G; Braun-Falco O
Hautarzt; 1976 Jun; 27(6):277-85. PubMed ID: 950302
[TBL] [Abstract][Full Text] [Related]
17. [UV-therapy of psoriasis. Half-side comparison between oral photochemotherapy (PUVA) and selective UV-phototherapy (SUP)].
Hönigsmann H; Fritsch P; Jaschke E
Z Hautkr; 1977 Nov; 52(21):1078-82. PubMed ID: 930225
[No Abstract] [Full Text] [Related]
18. Response of psoriatic nails to oral photochemotherapy.
Marx JL; Scher RK
Arch Dermatol; 1980 Sep; 116(9):1023-24. PubMed ID: 7416754
[TBL] [Abstract][Full Text] [Related]
19. PUVA treatment of the nasal cavity improves the clinical symptoms of allergic rhinitis and inhibits the immediate-type hypersensitivity reaction in the skin.
Csoma Z; Koreck A; Ignacz F; Bor Z; Szabo G; Bodai L; Dobozy A; Kemeny L
J Photochem Photobiol B; 2006 Apr; 83(1):21-6. PubMed ID: 16406552
[TBL] [Abstract][Full Text] [Related]
20. Photochemotherapy for psoriasis.
Roenigk HH; Martin JS
Arch Dermatol; 1977 Dec; 113(12):1667-70. PubMed ID: 596894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
